37
total announcements
TATVA.NS · 15 min delayed
Key Stats · Yahoo Finance · as of 15 Oct 2026
Market Cap
₹4,539 Cr
P/E (TTM)
88.3
P/E (Forward)
47.5
EPS (TTM)
₹21.97
52W Low
₹1,044.10
52W High
₹2,008.70
Dividend Yield
0.11%
Beta
0.30
Price / Book
5.8
Debt / Equity
15.4
Revenue (TTM)
₹556 Cr
Gross Margin
56.57%
Operating Margin
13.01%
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited has informed the Exchange about a scheduled analyst/institutional investor meet on July 31, 2026, with Motilal Oswal AMC, to be held virtually.
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited has informed the Exchange about the schedule of an analyst/institutional investor meet/conference call on July 30, 2026, with Ventura Securities Limited.
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited has informed the Exchange about the schedule of an Analysts/Institutional Investor Meet/Con. Call, which will be held on 30 July 2026, and will be participated by the Company. The meeting will be a one-to-one meeting with Tamohara Investment Managers Pvt. Ltd. through a virtual meeting.
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited has informed the Exchange about the schedule of an investor meeting with Alchemy Capital Management on 28 July 2026, which will be a virtual meeting.
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited has informed the Exchange about the transcript of the earnings call held on 17 July 2026 post announcement of financial results for the quarter ended 30 June 2026.
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited has informed the Exchange about the schedule of an analyst/institutional investor meet/conference call. The company will participate in a virtual meeting on July 27, 2026, hosted by ULJK Financial Services Pvt. Ltd. The meeting will refer to publicly available information and will not share any confidential or unpublished price-sensitive information.
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited has held a groundbreaking ceremony for its new greenfield unit at Dahej - III, Gujarat, India, as part of its growth strategy to meet growing market demands.
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited has informed the Exchange about Copy of Newspaper Publication of extract of financial results of the Company for the quarter ended 30 June 2026.
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited has made available the recording of its earnings call held on July 17, 2026, on its website.
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited has informed the Exchange about Investor Presentation for the quarter ended 30June2026, with consolidated financial highlights showing a 43% YoY increase in revenue from operations to ₹1,671 crore, and a 86% YoY increase in EBITDA to ₹323 crore.
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited has informed the Exchange about Capacity addition. The Board has approved the proposed capacity expansion (addition) of manufacturing capacities of various specialty chemicals at the new greenfield unit at Dahej - III, Dahej Industrial Estate, Taluka: Vagra, District: Bharuch, Gujarat, India.
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited has informed the Exchange regarding Change in Director(s) of the company, including the re-appointment of three directors and the approval of a proposed capacity expansion and increase in borrowing limits.
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited has submitted its unaudited financial results for the quarter ended June 30, 2026, and announced the re-appointment of its Managing Director and Whole-time Directors for a further period of three years. The company also approved a capacity expansion of its manufacturing capacities and an increase in its borrowing limits.
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited has informed the Exchange about the schedule of an earnings call post announcement of financial results for the quarter ended 30 June 2026. The call is hosted by ICICI Securities and is scheduled on Friday, 17 July 2026, at 05:00 p.m. (IST).
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming the securities received for dematerialisation during the quarter ended 30 June 2026.
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited has submitted a disclosure under SEBI Takeover Regulations, as per Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited has announced the closure of its trading window for designated persons and their immediate relatives. This closure, effective from July 1, 2026, will remain in effect until 48 hours after the company declares its unaudited financial results for the quarter ending June 30, 2026. This action is a standard compliance measure under SEBI (Prohibition of Insider Trading) Regulations, 2015, aimed at preventing insider trading before financial disclosures. Such intimations are routine regulatory filings.